Mereo BioPharma and Sentynl Therapeutics sign licensing deal for alvelestat

Alvelestat is designed to inhibit neutrophil elastase, an enzyme linked to inflammation and lung tissue damage. Credit: NMK-Studio / Shutterstock.com.